Cardiometabolic Medicine
The need for consistent updates and agile content is imperative for today’s clinician to remain current on the continuum of scientific data. In no therapeutic area is this more essential than in “Cardiometabolic Medicine,” a new term meant to encompass the interconnected and debilitating diagnoses of diabetes mellitus, heart failure, coronary artery disease/acute coronary syndrome, progressive renal insufficiency, and related disorders such as hypertension, hyperlipidemia, and hyperkalemia. These areas are subject to frequent pivotal trial publications, guidelines updates, FDA action, and outcomes assessments.
Our Tweetorials
Your new source for free CE/CME via Twitter!
Each program provides 0.5hr – 1.0hr credit for physicians, pharmacists, and nurses.
The FAB-ulous Tweetorial
From reversal agents to lipid-lowering agents, tailored antibodies target intrinsic molecules or pharmaceutical agents with very high specificity....
DAPT in Secondary Prevention of Stroke
@WorldStrokeCampaign @American_Stroke @WorldStrokeOrg @neurocriticalcare @MainaliShradda @vcurrutiaMD @almuftifawaz @drdangayach @AlexChebl...
New ASA Formulation for Secondary Prevention of CV Events
. . . but a different site of absorption--with greater predictability than ECASA. DON'T MISS IT!! @DLBHATTMD @cpcannon @AnnMarieNavar @DrM_ODonoghue...
MRAs: Why Might Nonsteroidal Agents Be Better?
@drkevinfernando @kidney_boy @KateIsabelle24 @SantosGallegoMD @aayshacader @VietHeartPA @Lross246 @SeguraCardio @ValleAlfonso @edgarvlermamd...
Factor XI and the Critical Difference Between Inhibiting Thrombosis and Inhibiting Hemostasis
https://twitter.com/cardiomet_CE/status/1452931243562127363 https://twitter.com/cardiomet_CE/status/1452931251799789572...
Antiplatelet Therapy in STEMI Complicated by Cardiogenic Shock
FOLLOW US now and be there! @DLBHATTMD @DrMauricioCohen @SVRaoMD @HeartBobH @HeartOTXHeartMD @Heart_SCCT @TCTMD @GreggWStone @gabrielsteg @cpcannon...
The Kidney as “the Canary in the Coal Mine for Cardiovascular Health.”
Don't get the reference? You will! And you'll get amazing education from the founder of https://t.co/o7hcEGYQCB, just for you! JUST FOR FOLLOWING!...
Revisit the Recent #EASD2021 Conference
1 Just to remind you guysThe @GoggleDocs are a bunch of 🇬🇧 docs/🤓 who are fascinated about the cardio-metabolic conditions we are increasingly...
Introduction to NAFLD/NASH
Be sure to join here TOMORROW for our FIRST @cardiomet_CE accredited #tweetorial on non-alcoholic fatty #liver disease (#NAFLD) / non-alcoholic...
A Review of Antithrombotic Reversal
Yes, join here Tuesday for CE/#CME for a review of antithrombotic reversal by expert author @md_pollack. Check it out, @CardioNerds @beaverspharmd...
@Cardiomet_CE on Twitter
Your only source for ACCREDITED SoMe-delivered
serialized professional cardiometabolic education. Physicians, nurses, pharmacists–come one, come all!
On Twitter at @cardiomet_ce, we present a series of tweetorials, Twitter-delivered case studies, and Twitter Journal Clubs, each accredited for 0.5hr – 1.0hr CE/CME. Programs are presented by expert faculty in engaging and fully interactive format. Our unique program harnesses the reach, up-to-the-minute currency, and accessibility of social media to deliver a constant flow of accredited, interactive, expert-delivered educational programs to a multidisciplinary and interprofessional audience of engaged clinicians.
Completed programs appear “unrolled” on this webpage, but to maximize the learning value of these innovative programs, please follow @cardiomet_ce.
#CardioTwitter #surgery #bleeding https://twitter.com/cardiomet_CE/status/1466383152507768837
30) Interim analysis of the Phase 3 data on bentracimab were presented by @DLBHATTMD at #AHA21 and will be published early next year. Here is the Fab-consistent mechanism of action of bentracimab and a look at the Phase 1 data:
@cardiomet_CE For those interested, the REVERSE-IT interim data are now available at @NEJMEvidence - https://evidence.nejm.org/pb-assets/evidence-site/content/EVIDoa2100047-1638377642183.pdf #CardioTwitter @NEJM
